Vaxart (VXRT)

• Market cap: $162M
• 1 day: 1.21%
• 5 days: -4.88%
• 1 month: -6.67%
• 3 months: 19.06%
• 6 months: -23.01%
• Year to date: -0.72%
• 1 year: -49.40%
• 5 years: -34.54%
• 10 years: -96.02%
• Sector: Healthcare
• Industry: Biological Products, Except Diagnostic Substances

About: Vaxart Inc is a clinical-stage biotechnology company. It focuses on the development of oral recombinant vaccines to protect against a wide range of infectious diseases. The products under its tablet pipeline consist of the treatment of Coronavirus, Norovirus, Seasonal Influenza, RSV(respiratory syncytial virus), and HPV(Human papillomavirus) Therapeutic. It operates in a single segment, which is the discovery and development of oral recombinant protein vaccines. Geographically all the business activity functions through the region of the United States.

Employees: 109

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

15% more call options, than puts

Call options by funds: $133K | Put options by funds: $116K

0.81% less ownership

Funds ownership: 16.52% [Q3] → 15.71% (-0.81%) [Q4]

4% less repeat investments, than reductions

Existing positions increased: 23 | Existing positions reduced: 24

8% less funds holding

Funds holding: 100 [Q3] → 92 (-8) [Q4]

28% less first-time investments, than exits

New positions opened: 13 | Existing positions closed: 18

30% less capital invested

Capital invested by funds: $33.9M [Q3] → $23.7M (-$10.2M) [Q4]

100% less funds holding in top 10

Funds holding in top 10: 1 [Q3] → 0 (-1) [Q4]